There are 749 resources available
LBA6 - First China-manufactured trastuzumab biosimilar HLX02 global phase III trial met primary endpoint in breast cancer
Presenter: Binghe Xu
Session: Proffered paper session - Breast cancer
Resources:
Abstract
Invited Discussant 25O and LBA6
Presenter: Sung-Bae Kim
Session: Proffered paper session - Breast cancer
Resources:
Slides
Invited Discussant 37O and 38O
Presenter: Yoon Sim Yap
Session: Proffered paper session - Breast cancer
Resources:
Slides
Webcast
Introduction
Presenter: George Pentheroudakis
Session: ESMO Clinical Practice Guidelines session
Resources:
Slides
Webcast
Cervical cancer
Presenter: Sudeep Gupta
Session: ESMO Clinical Practice Guidelines session
Resources:
Slides
Webcast
Immunotherapy in advanced NSCLC
Presenter: Myung-Ju Ahn
Session: ESMO Clinical Practice Guidelines session
Resources:
Slides
Webcast
Medical oncology on improved pathological classification of tumours
Presenter: Silvia Stacchiotti
Session: The interface between histopathology, genomics and therapy
Resources:
Slides
Webcast
ESMO recommendations for detecting MSI and TRK fusion (using NGS?)
Presenter: Caterina Marchiò
Session: ESMO – KSMO Collaborative Session: Going towards an agnostic treatment / approach
Resources:
Slides
Webcast
DDR pathway with gBRCA mutation in Korean cancer patients
Presenter: Seock-Ah Im
Session: ESMO – KSMO Collaborative Session: Going towards an agnostic treatment / approach
Resources:
Slides
Webcast
Precision Medicine in prostate cancer
Presenter: Cora Sternberg
Session: Precision medicine for GU cancer
Resources:
Slides
Webcast